-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A7gRQxLilhldBVA1TwANltKZ4pWEo2DNHh3jwGBA175aorzpAuWvf7UJvmAHLQ6H VstIhUHS0mg8KU9vB75glg== 0000893838-06-000055.txt : 20060503 0000893838-06-000055.hdr.sgml : 20060503 20060503210815 ACCESSION NUMBER: 0000893838-06-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050912 FILED AS OF DATE: 20060503 DATE AS OF CHANGE: 20060503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2402685300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLADAY JOHN W DR CENTRAL INDEX KEY: 0001033741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50590 FILM NUMBER: 06805782 BUSINESS ADDRESS: STREET 1: 9610 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3012179858 4 1 rexform4holaday_ex.xml X0202 4 2005-09-12 0 0001228627 REXAHN PHARMACEUTICALS, INC. RXHN 0001033741 HOLADAY JOHN W DR 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 1 0 0 0 Stock option (right ot buy) 0.24 2005-12-08 4 D 0 70000 D 2013-08-05 Common stock 100000 30000 D Stock option (right ot buy) 0.80 2005-12-08 4 A 0 70000 A 2013-08-05 Common stock 70000 70000 D Stock option (right ot buy) 0.24 2005-12-08 4 D 0 125000 D 2014-04-20 Common stock 125000 0 D Stock option (right ot buy) 0.80 2005-12-08 4 A 0 125000 A 2014-04-20 Common stock 125000 125000 D Stock option (right ot buy) 3.00 2005-09-12 4 A 0 20000 0 A 2006-09-12 2015-09-12 Common stock 20000 20000 D Stock option (right ot buy) 0.80 2006-05-01 4 D 0 70000 D 2016-05-02 Common stock 70000 0 D Stock option (right ot buy) 0.80 2006-05-01 4 A 0 70000 A 2016-05-02 Common stock 70000 70000 D Stock option (right ot buy) 0.80 2006-05-01 4 D 0 125000 D 2016-05-02 Common stock 125000 0 D Stock option (right ot buy) 0.80 2006-05-01 4 A 0 125000 A 2016-05-02 Common stock 125000 125000 D Stock option (right ot buy) 3.00 2006-05-01 4 D 0 20000 D 2016-05-02 Common stock 20000 0 D Stock option (right ot buy) 3.00 2006-05-01 4 A 0 20000 A 2016-05-02 Common stock 20000 20000 D As of August 5, 2005, 60% of the options were vested; the remaining 40% of the options vest and become exercisable on August 5, 2006. The transaction involved an amendment of outstanding options to change the exercise price with respect to 70,000 options from $0.24 to $0.80, resulting in the deemed cancellation of a portion of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options. As of April 20, 2006, 60% of the options were vested; the remaining 40% of the options vest and become exercisable on April 20, 2007. The transaction involved an amendment of outstanding options to change the exercise price with respect to 125,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options. Pursuant to an agreement dated May 2, 2006, all of Dr. Holaday's options vest and become exercisable immediately upon his termination of service as director of Rexahn Pharmaceuticals, Inc. and may be exercised until 10 years after the original date of grant. The transaction involved an amendment of outstanding options to accelerate vesting and extend the exercise period pursuant to an agreement dated May 2, 2006, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options. /s/ Ted T.H. Jeong as attorney-in-fact for John Holaday 2006-05-03 -----END PRIVACY-ENHANCED MESSAGE-----